AllDocs -> cancers

g?2 SHIP g?2 SHPI g?2 SHPP g?2 RPPQ g?2 SPHI g?2 RPPI g?2 SHIIFHP g?2 RPPP g?2 SPHPFHP g?2 RPPS g?2 RPPT g?2 SHIIFHI g?2 RPPR g?2 SPHPFHI g?2 RPPU g?2 RPPV Figure 5 Lung Cancer Incidence Among Males and Females Combined 1993-1998 Abington, Hingham, Rockland, and Weymouth, Massachusetts source data supplied by the Massachusetts Executive Office of Environmental Af airs, MassGIS, Geographic Data Technology, Inc, and U.S. Bureau of the Census 2 0 2 1 Miles SIR = or < expected SIR > expected SIR statistically significantly > expected South Weymouth Naval Air Station Census Tract (CT) Boundary

g?2 SHIP g?2 SHPI g?2 SHPP g?2 RPPQ g?2 SPHI g?2 RPPI g?2 SHIIFHP g?2 RPPP g?2 SPHPFHP g?2 RPPS g?2 RPPT g?2 SHIIFHI g?2 RPPR g?2 SPHPFHI g?2 RPPU g?2 RPPV Figure 4 Lung Cancer Incidence Among Males and Females Combined 1987-1992 Abington, Hingham, Rockland, and Weymouth, Massachusetts source data supplied by the Massachusetts Executive Office of Environmental Af airs, MassGIS, Geographic Data Technology, Inc, and U.S. Bureau of the Census 2 0 2 1 Miles SIR = or < expected SIR > expected SIR statistically significantly > expected South Weymouth Naval Air Station Census Tract (CT) Boundary

g?2S HIP g?2S HPI g?2S HPP g?2R PPQ g?2S PHI g?2R PPI g?2S HIIFHP g?2R PPP g?2S PHPFHP g?2R PPS g?2R PPT g?2S HIIFHI g?2R PPR g?2S PHPFHI g?2R PPU g?2R PPV Figure 2 Lung Cancer Incidence Among Males and Females Combined 1982-1998 Abington, Hingham, Rockland, and Weymouth, Massachusetts source data supplied by the Massachusetts Executive Office of Environmental Affairs, MassGIS, Geographic Data Technology, Inc, and U.S. Bureau of the Census 2 0 2 1 Miles SIR = or < expected SIR > expected SIR statistically significantly > expected South Weymouth Naval Air Station Census Tract (CT) Boundary

g?2 SHIP g?2 SHPI g?2 SHPP g?2 RPPQ g?2 SPHI g?2 RPPI g?2 SHIIFHP g?2 RPPP g?2 SPHPFHP g?2 RPPS g?2 RPPT g?2 SHIIFHI g?2 RPPR g?2 SPHPFHI g?2 RPPU g?2 RPPV Figure 3 Lung Cancer Incidence Among Males and Females Combined 1982-1986 Abington, Hingham, Rockland, and Weymouth, Massachusetts source data supplied by the Massachusetts Executive Office of Environmental Af airs, MassGIS, Geographic Data Technology, Inc, and U.S. Bureau of the Census 2 0 2 1 Miles SIR = or < expected SIR > expected SIR statistically significantly > expected South Weymouth Naval Air Station Census Tract (CT) Boundary

Guidance on Commissioning Cancer Services Improving Outcomes in Lung Cancer The Manual G O O D P R A C T I C E Page 2 Contact Point Triona Norman NHS Executive Health Services Directorate Wellington House London SE1 8UG Further copies from Department of Health PO Box 410 Wetherby LS23 7LL Catalogue number 97CC122 Date of issue June 1998 G O O D P R A C T I C E Examples of and advice on good practice Purpose of this document This booklet is intended to help those planning and commissioning cancer services, in partnership with local hospitals and the community to improve the quality of care for people with lung cancer or those at higher risk of developing the disease. It is intended to support the ongoing implementation of the ...

Diagnosis to Treatment in Two Weeks The FMH Regional Cancer Therapy Center introduces a new concept in lung cancer care: The Multidisciplinary Lung Cancer Clinic Contact the Navigator at: 301-694-5517 The Multidisciplinary Lung Cancer Clinic will provide patients with suspected or newly diagnosed lung cancer , immediate interaction with a team of consultants to include: • Medical Oncologist • Radiation Oncologist • Thoracic Surgeon • Pulmonologist The consultations will take place in one day , in one clinic at the FMH Regional Cancer Therapy Center Patients will have the guidance and support of a “Navigator” who will guide them through the treatment process. Patient Navigator Amy Seek, RN, CRNP discusses treatment plans with a patient. ...

Grants funded by the Kentucky Lung Cancer Research Program Principal Investigator Grant Title Mansoor M Ahmed Timothy Aldridge TGF-beta signaling and radiation response in lung carcinoma Lung cancer in Kentucky – environmental/occupational factor Bradley D. Anderson Anti-topoisomerase I aerosols for lung cancer therapy Douglas A. Andres Novel Ras-related GTPase in lung cancer Susanne M. Arnold Andre Baron Low-dose fractionated radiation plus Docetaxel and Cisplatin as induction therapy for state II and IIIA non-small cell lung cancer Evaluating low dose computed tomography and serum biomarkers for lung cancer screening Paula J. Bates Nucleolin: A novel marker and therapeutic target for lung cancer Haribabu Bodduluri ...

lung cancer Lung Cancer Michael A. Jantz, MD Assistant Professor of Medicine Division of Pulmonary and Critical Care Medicine University of Florida Epidemiology Estimated 156,000 deaths due to lung cancer in US in 2000 Estimated 17,000 deaths due to lung cancer in Florida in 2000 Deaths due to lung cancer greater than breast, prostate, and colon combined Epidemiology Cigarette smoking is the leading cause of lung cancer Epidemiology Quitting smoking does modify risk for lung cancer Epidemiology For given level of smoking, relative risk for females developing lung cancer is higher (RR 1.9) Environmental tobacco smoke (ETS) Does increase risk of lung cancer Relative risk in nonsmokers exposed to ETS 1.2-1.7 ~2-3% of ...

S pecial A rticle Management of elderly patients with lung cancer K.N. Syrigos 1 , G. Dionelis 2 ABSTRACT. The majority of patients with lung cancer (LC) are elderly patients, since 60% of the newly diagnosed patients with LC are >65 years old and 30% are >70 years old. It is common for elderly patients to suffer from a variety of chronic diseases and hence receive multiple drug treatments, which combined with their particular psychosocial and financial situation makes the process of diagnosis, staging and treatment of the disease difficult; there- fore, it is necessary to employ an individualized approach. We thor- oughly reviewed the differences between elderly and younger pa- tients with lung cancer and pinpoint the need for an individual- ized approach to the management of elderly patients with lung ...

Kentucky Lung Cancer Research Program Clinical Trials for Practicing Physicians Creating the Commonwealth’s Clinical Trials Network Business Meeting #1 Minutes August 21, 2002 Opening : Dr. Timothy Wm. Mullett, program facilitator, called this first business meeting of the Commonwealth Clinical Trials Network (CTNN) to order at 4:40 p.m. on August 21, 2002 at the Kentucky History Center in Frankfort, Kentucky. Present : Richard Arnold, MD Richard Seither, MD Susanne Arnold, MD Connie Sorrell, PhD Harry Carloss, MD Marguerite Sellitti, MD Greg Carlsen, MD Satish Shah, MD Alfred Cohen, MD Subhash Sheth, MD Steve Ellis, PhD Mark Sobczak, MD Richard Gruenewald, MD Amy Tabb, PhD Dermot Halpin, MD Charles Webb, MD Marta Hayne, MD Karen Clancy Fred Hendler, MD, PhD Robin Cline ...

Mayo School of Continuing Medical Education LUNG CANCER Multi-Modality Management of Lung Cancer : Future Prospects S Y M P O S I U M M A Y O C L I N I C August 20–22, 2004 Mayo Clinic Rochester, Minnesota COURSE DIRECTOR: Alex A. Adjei, M.D., Ph.D . Page 2 General Information Course Description & Objectives Lung cancer is the leading cause of cancer deaths in both men and women in the United States. Even though it is the third most common cancer , it accounts for 28% of all cancer deaths. The prevention, diagnosis and treatment of this cancer requires close collaboration between a number of scientific and medical disciplines. Unfortunately, there are few opportunities for individuals in these professions to come ...

Lung cancer rates as an index of tobacco smoke exposures: validation against black male fnon- lung cancer death rates, 1969–2000 Bruce Leistikow, M.D., M.S.* Department of Epidemiology and Preventive Medicine, University of California, Davis, Davis, CA 95616, USA Abstract Background. Researchers use lung cancer death rates (rates) as an index of the cumulative burdens of smoking. That index lacks direct validation and calibration. So this study directly validates and calibrates that index against annual fnon- lung (all-sites minus lung and stomach) rates from 1969 to 2000 in United States black men, then estimates their cancer death rate smoking-attributable fractions (SAFs). Methods. This study uses linear regression, age-adjusted rates from http://www.seer. cancer .gov/canques, and the formula SAF = (1 À ((rate in the unexposed) / (rate in the exposed))). Estimated rates in the unexposed ...

The principal cause of lung cancer is smoking and the reduction in smoking in men is reflected in a corresponding reduction of death by this disease. However, the high level of smoking that was common in men has left its legacy as lung cancer is the biggest cause of death due to malignant neoplasm, causing nearly 8% of all deaths for the men in the 17 countries of the study. The countries that have maintained a high level of smoking have correspondingly high levels of cancer of the larynx, trachea, bronchus and lung . In Belgium, where 36% of men declare that they smoke (see figure 17.2), having over 11% of its total deaths for men as a result of lung cancer as compared to Sweden, with 18% of its male population declaring to smoke, with only 4%. Figure 6.1 Deaths due to malignant neoplasm of larynx, trachea, bronchus and lung , for men, as a percentage ...

Lung Cancer Lung cancer progresses rapidly. The median survival time after diagnosis is less than four months, and about 80% of patients die within one year. Symptoms Symptoms may include cough (which may bring up blood), chest pain, breathlessness and continuous hoarseness of voice. One may also find tiredness, loss of appetite, weight loss, and repeated chest infections. The tumour may not show any early signs, with the first indications being due to the effects of cancer that has spread to other parts of the body. The most common sites of lung cancer metastases are the brain, liver and bones. Types of lung cancer Lung cancer is split into two main categories: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). The most common is NSCLC, which accounts for approximately ...

Lung Cancer Survey 2001 Page 2 Figure 1. Smoking History - 131 newly diagnosed lung cancer patients at Stony Brook Hospital in 2001 Current 54% Former 37% Never 6% Unknown 3% Current Former Never Unknown Page 3 Figure 2. Gender distribution for lung cancer patients at Stony Brook Hospital in 2001 compared to National Cancer Data Base 1994-1998 benchmark report. 0% 10% 20% 30% 40% 50% 60% 70% Males Females Stony Brook NCDB Page 4 Figure 3. Age at diagnosis of lung cancer at Stony Brook Hospital in 2001 compared to National Cancer Database 1994-1998 benchmark report. 0 10 20 30 ...

EMBARGOED FOR RELEASE Contact: Amanda Widtfeldt Tuesday, April 13, 3 p.m. CT 312.926.2955 awidtfel@nmh.org Lung Cancer in Women Is a 21 st Century Epidemic Northwestern Memorial lung cancer specialist publishes ‘special communication’ in JAMA calling for targeted research on women CHICAGO – Future lung cancer research needs to include gender-specific studies to address the important differences that exist between men and women with lung cancer , according to a paper published in the April 14 issue of the Journal of the American Medical Association (JAMA). “ Lung cancer appears to be a different disease in women,” says the paper’s lead author Jyoti Patel, M.D., an oncologist at Northwestern Memorial Hospital and an instructor of medicine at the Feinberg School of Medicine of Northwestern University. Differences ...

Weill Medical College of Cornell University 1300 York Avenue New York, NY10021 Telephone: (212) 746-1325 Why would I want to have a lung cancer screening CT? The best hope for curing lung cancer is finding it as early as possible. If you are at risk, this new test is able to detect tiny irregularities in your lungs (called nodules) that may be indicative of lung cancer in its earliest stage. Who is considered "at-risk?" You may be at risk if you are a current or former smoker and 40 or more years of age. I have had chest x-rays before, why would I want to have this scan? Will I benefit from a low dose lung cancer screening CT? A chest x-ray only shows two views of your chest (front and side), while a CT scan shows over 300 cross-sectional images throughout ...

TOBACCO-USE PREVENTION AND CESSATION AND LUNG CANCER C H A P T E R 5 Page 2 C o m m i t t e e M e m b e r s Kari Appler (Chairperson) - Smoke Free Maryland Dawn Berkowitz, MPH - Center for Health Promotion and Tobacco-Use Prevention, Maryland Department of Health & Mental Hygiene Marsha Bienia, MBA - Center for Cancer Surveillance and Control, Maryland Department of Health & Mental Hygiene Albert Blumberg, MD - Greater Baltimore Medical Center Mark Breaux - Smoke Free Maryland Christine Crabbs - North Arundel Hospital Kathleen Dachille, JD - Center for Tobacco Regulation, University of Maryland School of Law Michaeline Fedder, MA - American Heart Association Patricia N. Horton, RN, MBA - Montgomery County Health Department Soula Lambropoulos, MS - Baltimore City Health Department Ruth Maiorana - Harford County ...

EDITORIAL A Perspective on Cytology of Lung Cancer [Indian J Chest Dis Allied Sci 2004; 46 : 81-83] The dawn of the last century was still early days for carcinoma lung , when it was regarded as an uncommon form of malignancy. A signi- ficant rise in the incidence of lung cancer was noticed at the end of World War I, the occur- rence closely correlated with the degree of atmospheric pollution and density of popula- tion. Besides these, personal habits like cigarette smoking and occupation also had an effect. During the second half of the last century an increase in size and ageing of the population have contributed to the increase in absolute numbers of lung cancer every year. It is presently considered one of the most common and deadly malignancies throughout the world. To date, the public health measures and thera- peutic advances have ...

IMPROVING THE MANAGEMENT OF LUNG CANCER Saturday 5 April 2003 Adelaide Convention Centre North Terrace Adelaide South Australia workshop summary Page 2 8<?A>E8=6 C74 <0=064<4=C >5 ;D=6 20=24A A report of the workshop held 5 April 2003 at the Adelaide Convention Centre North Terrace Adelaide SA Page 3 Improving the Management of Lung Cancer A summary of the workshop held 5 April 2003 in Adelaide, South Australia. National Cancer Control Initiative 1 Rathdowne Street Carlton Vic 3053 Australia Tel: +61 (0)3 9635 5108 Fax: +61 (0)3 9635 5320 Email: enquiries@ncci.org.au Internet: www.ncci.org.au Published December 2003 ISBN 1 876992 05 0 © National Cancer Control ...

“The Biology of Nicotine and Tobacco: Bench to Bedside" April 23, 2004 Gaithersburg Hilton Hotel Sponsored by the Lung Cancer and Upper Aerodigestive Faculty Preliminary Agenda (as of April 8, 2004) 8: 00 a.m. Business Meeting and Retreat Registration 8:30 a.m. RETREAT OPENING PLENARY Opening Remarks Robert Wiltrout, Ph.D., Laboratory of Experimental Immunology, CCR, NCI 8:40 a.m. “NF-?B and the Proteasome in Pathogenesis and Therapy of Head and Neck Cancer ” Carter Van Waes, M.D., Ph.D., Head and Neck Surgery Branch, NIDCD 9:20 a.m. “Head and Neck Cancer and Signaling Networks: Emerging Paradigms” J. Silvio Gutkind,Ph.D., Oral and Pharyngeal Cancer Branch, DIR, NIDCR 10:10 a.m. Break and Posters 10:25 a.m. “Pharmacology and Regulation of Neuronal Nicotinic Receptors” Kenneth Kellar, Ph.D., Georgetown University ...

lung cancer Lung Cancer Overview A Slide Presentation for Oncology Nurses Lung Cancer : What is it? Uncontrolled growth of malignant cells in one or both lungs and tracheo-bronchial tree Arises from protective or ciliated cells in the bronchial epithelium Begins as a result of repeated carcinogenic irritation causing increased rates of cell replication Proliferation of abnormal cells leads to hyperplasia, dysplasia or carcinoma in situ Lung Cancer : Incidence in US 173,770 new cases yearly (2004 statistics) 160,440 deaths yearly (2004 statistics) More deaths from lung cancer than prostate, breast and colorectal cancers combined Closely correlated with smoking patterns Decreasing incidence and deaths in men; continued increase in women Incidence and mortality rates higher for African Americans than white Americans ...

Lung cancer M.Haitham Bakir, MD FCCP Pulmonary department Southern Illinois University Page 2 Question • Which statement is true : 1- breast cancer is the leading cause of death in women followed by lung cancer . 2- mortality from lung and stomach cancer has been rising 3- ten percent of patients with lung cancer are under 40YO 4- lung cancer deaths increasing in men more than women 5- lung cancer is the most common malignant tumor in men throughout the world. Page 3 Epidemiology • Most common cancer in the world. • Most common cause of cancer -related death in both men and women, W>>M. • Incidence increase in men and women. • Overall incidence in US 38.5 per 100,000 Page 4 Risk factors • Smoking, ...

1 The second Kyoto Lung Cancer Forum Preface It is great honor and pleasure for all of us, participants, to have the second conference of "Kyoto Lung Cancer Forum" also this year. The treatment of lung cancer is now coming to so-called “individualization”. The title of the Second Kyoto Lung Cancer Forum is “MOLECULAR TARGETING FOR LUNG CANCER ”. In the conference we are intending to have presentations concerning Dr. Swisher from MD Anderson cancer research center will lecture on gene therapy strategies for lung cancer , especially p53 gene therapy. Dr. Saya from Kumamoto university and Dr. Takenaka of Kyoto university will speak about the candidates of new target genes, CD44 and RECK. Interestingly both of them are involved to regulation of extra-cellular matrix and play a critical role in cancer invasion. Then, Dr. Sekido from ...

Introduction Enolase is a glycolytic cytoplasmic enzyme, present in all human cells, catalysing the con- version of 2-phosphoglycerate to 2-phospho- enolpyruvate. 1 The enzyme consists of thrree dimeric isoenzymes, called as a, ß and ?. Neuron specific enolase (NSE) is ?-? dimer and presents the neuronal form of the eno- lase. 2 Originally extracted from the bovine Radiol Oncol 2004; 38(1): 21-6. Neuron specific enolase - selective marker for small-cell lung cancer Biljana Ilievska Poposka 1 , Mirko Spirovski 2 , Dean Trajkov 2 , Tome Stefanovski 3 , Sonja Atanasova 1 , Marija Metodieva 1 1 Institute for Lung Diseases and Tuberculosis, Clinical Center, Skopje 2 Institute for ...

254 · Ju l y 2 7 , 2 0 0 0 The Ne w E n g l a nd Jo u r n a l o f Me d ic i ne PREOPERATIVE STAGING OF NON–SMALL-CELL LUNG CANCER WITH POSITRON-EMISSION TOMOGRAPHY R EMGE M. P IETERMAN , M.D., J OHN W.G. VAN P UTTEN , M.D., J ACOBUS J. M EUZELAAR , M.D., E DUARD L. M OOYAART , M.D., W ILLEM V AALBURG , P H .D., G ERARD H. K OËTER , M.D., V ACLAV F IDLER , P H .D., J AN P RUIM , M.D., AND H ARRY J.M. G ROEN , M.D. A BSTRACT Background Determining the stage of non–small- ...

Web Immagini Gruppi Directory News Novità! Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:wE_6KLlLS64J:www.nrpb.org/publications/bulletin/archive/bulletin_224/e224_5.pdf allintitle: lung cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

Lung Cancer and Mesothelioma During Prospective Surveillance of 1249 Asbestos Insulation Workers, 1963-1974* Irving J. Selikoff Environmental Sciences Laboratory Mount Sinai School of Medicine The City University of New York New York, New York 10029 INTRODUCTION In 1963, it was found that a large group of asbestos insulation workers in the New York metropolitan area had experienced unusual mortality during 1943-1962. 1 Six hundred and thirty-two men had been on the union's rolls on January 1, 1943. By December 31, 1962, 262 men had died, nine before reaching 20 years on the job. Of those who died after 20 years from first employment, lung cancer was found in marked excess; 6.02 such deaths had been expected, and 42 occurred. In addition, there were several deaths due to pleural or peritoneal mesothelioma and a modest increase in deaths due to, gastrointestinal ...

Post chemotherapy color volume rendering showing a significant decrease in the size of the mass to 120cc Pre and Post Chemotherapy Assessment of Lung Cancer Presented by Russell N Low M.D., Medical Director, Sharp and Children’s MRI Center, San Diego A 77 year-old-male presented with lung cancer . Radiology work-up included a contrast-enhanced MRI examination of the chest immediately prior to and following chemotherapy. Oncology Color volume rendered view demonstrating a 260cc mass in the left lower lobe prior to chemotherapy © Copyright 2002 Voxar Inc. All rights reserved. Printed in the UK: M 231/VI REV 01-10/03. Voxar, the stylized X logo and Voxar 3D logo are trademarks of Voxar Limited. “Appreciating changes in tumor size is often difficult or incomplete based upon a stack of 2D images alone. Tumors after all are 3D structures.” ...